Novel agent for Helicobacter pylori infection management.
- Author:
Ramin MOHAMMADZADEH
1
;
Nejla AHMADIYAN
Author Information
1. Biotechnology Research Center, Students Research Committee, Faculty of Pharmacy, Tabriz University (Medical Sciences), Tabriz, Iran.
- Publication Type:Letter
- MeSH:
Animals;
Anti-Bacterial Agents;
administration & dosage;
Escherichia coli;
Female;
Galactosylceramides;
immunology;
Gastric Mucosa;
pathology;
Gastritis, Atrophic;
pathology;
Helicobacter Infections;
complications;
drug therapy;
Helicobacter pylori;
pathogenicity;
Humans;
Inflammation;
pathology;
Intestines;
microbiology;
Levofloxacin;
Lymphocyte Activation;
Male;
Natural Killer T-Cells;
microbiology;
Ofloxacin;
administration & dosage;
Sphingomonas;
Stomach;
pathology
- From:
Chinese Medical Journal
2013;126(23):4535-4535
- CountryChina
- Language:English
